BPC-157 (Body Protection Compound-157) is a pentadecapeptide consisting of 15 amino acids derived from a larger protective protein in human gastric juice
The elevated concentration provides enhanced therapeutic effects through increased growth factor expression, accelerated angiogenesis, and more robust anti-inflammatory action
No Phase 2 or Phase 3 clinical trial has been completed or published
At low, carefully controlled doses, it is commonly used to support mental focus, memory, and overall brain health, as well as general energy levels
Kyal shares his wealth of knowledge and personal experiences, delving into how these powerful compounds can revolutionise our approach to health, especially for those of us dealing with chronic gut issues like Crohn's Disease
Routes of Administration Oral (only route): Capsule form, typically available in 50 mg capsules